The standard chemotherapy treatments for pediatric T-cell acute lymphoblastic leukemia (T-ALL) now achieve high cure rates. However, such aggressive chemotherapy in children has significant consequences on their quality of life. Moreover, the prognosis in case of relapse is very poor, with treatment resistance suggesting that chemotherapy fails to target leukemia stem cells. The objective of […]
Read More